| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |